U.S. stocks gain as Pfizer boosts Dow

U.S. stocks advanced modestly on Tuesday, helped at the margin by earnings from Pfizer Inc. and some delayed economic reports, but investors avoided big bets ahead of the Federal Reserve’s two-day meeting.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.